{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:01:26Z","timestamp":1758862886435,"version":"3.37.3"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["fertstertscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Science"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.xfss.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T20:05:21Z","timestamp":1613592321000},"page":"114-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fast forward: fibroid management in 2042"],"prefix":"10.1016","volume":"2","author":[{"given":"Malak","family":"El Sabeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa A.","family":"Borahay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfss.2021.02.002_bib1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.fertnstert.2012.10.048","article-title":"Biomarkers in uterine leiomyoma","volume":"99","author":"Levy","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.02.002_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41401-018-0184-6","article-title":"Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment","volume":"40","author":"Ali","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.xfss.2021.02.002_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.fertnstert.2019.10.015","article-title":"Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study!","volume":"113","author":"Ali","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.02.002_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/OGX.0000000000000718","article-title":"Cardiometabolic risk factors and benign gynecologic disorders","volume":"74","author":"AlAshqar","year":"2019","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.xfss.2021.02.002_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.fertnstert.2018.07.024","article-title":"Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production","volume":"110","author":"Malik","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.02.002_bib6","doi-asserted-by":"crossref","first-page":"733.e1","DOI":"10.1016\/j.ajog.2020.05.012","article-title":"Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells","volume":"223","author":"Afrin","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfss.2021.02.002_bib7","doi-asserted-by":"crossref","first-page":"35075","DOI":"10.1074\/jbc.M114.583575","article-title":"Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells","volume":"289","author":"Borahay","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xfss.2021.02.002_bib8","doi-asserted-by":"crossref","first-page":"196.e1","DOI":"10.1016\/j.ajog.2015.03.055","article-title":"Novel effects of simvastatin on uterine fibroids: in\u00a0vitro and patient-derived xenograft mouse model study","volume":"213","author":"Borahay","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfss.2021.02.002_bib9","doi-asserted-by":"crossref","first-page":"750.e1","DOI":"10.1016\/j.ajog.2016.06.036","article-title":"Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study","volume":"215","author":"Borahay","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfss.2021.02.002_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/1933719117750751","article-title":"Therapeutic roles of statins in gynecology and obstetrics: the current evidence","volume":"25","author":"Zeybek","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.xfss.2021.02.002_bib11","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1210\/clinem\/dgaa718","article-title":"Angiotensin-converting enzyme inhibitors reduce uterine fibroid incidence in hypertensive women","volume":"106","author":"Fischer","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["F&S Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X2100029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X2100029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T04:50:58Z","timestamp":1716526258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666335X2100029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2666335X2100029X"],"URL":"https:\/\/doi.org\/10.1016\/j.xfss.2021.02.002","relation":{},"ISSN":["2666-335X"],"issn-type":[{"type":"print","value":"2666-335X"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fast forward: fibroid management in 2042","name":"articletitle","label":"Article Title"},{"value":"F&S Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfss.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}